Ses of resource consumption. However, both the sensitivity analysis on costs and the small difference between the incremental cost-utility ratios with or without the cost savings due to the better health states of those patients taking pregabalin show that the expert panel findings do not influence the results. ItFigure 2 Cost-effectiveness acceptability curve.Silva Miguel et al. Cost Effectivenes